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Abstract
Disparate enveloped viruses initiate infection by fusing with endosomes. However, the highly diverse and dynamic nature of
endosomes impairs mechanistic studies of fusion and identification of sub-cellular sites supporting the nucleocapsid
release. We took advantage of the extreme stability of avian retrovirus-receptor complexes at neutral pH and of acid-
dependence of virus-endosome fusion to isolate the latter step from preceding asynchronous internalization/trafficking
steps. Viruses were trapped within endosomes in the presence of NH4Cl. Removal of NH4Cl resulted in a quick and uniform
acidification of all subcellular compartments, thereby initiating synchronous viral fusion. Single virus imaging demonstrated
that fusion was initiated within seconds after acidification and often culminated in the release of the viral core from an
endosome. Comparative studies of cells expressing either the transmembrane or GPI-anchored receptor isoform revealed
that the transmembrane receptor delivered the virus to more fusion-permissive compartments. Thus the identity of
endosomal compartments, in addition to their acidity, appears to modulate viral fusion. A more striking manifestation of the
virus delivery to distinct compartments in the presence of NH4Cl was the viral core release into the cytosol of cells
expressing the transmembrane receptor and into endosomes of cells expressing the GPI-anchored isoform. In the latter
cells, the newly released cores exhibited restricted mobility and were exposed to a more acidic environment than the
cytoplasm. These cores appear to enter into the cytosol after an additional slow temperature-dependent step. We conclude
that the NH4Cl block traps the virus within intralumenal vesicles of late endosomes in cells expressing the GPI-anchored
receptor. Viruses surrounded by more than one endosomal membrane release their core into the cytoplasm in two steps –
fusion with an intralumenal vesicle followed by a yet unknown temperature-dependent step that liberates the core from
late endosomes.
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Introduction
A large number of enveloped and non-enveloped viruses enter
cells through endocytosis [1]. Depending on the nature of cellular
receptors and replication strategies, viruses have evolved to utilize
alternative entry routes and fuse with distinct intracellular
compartments. Preferential entry from early or late endosomes is
achieved through adjusting the pH threshold for triggering fusion
[2–4] or by relying on endosome-specific factors, such as lipids [5–
7] or lysosomal enzymes [8,9]. There is evidence for complex
regulation of early and late steps of viral fusion. For instance,
viruses, which are activated by mildly acidic pH in early
endosomes, may require late endosome-resident factors to
complete their fusion process and release the nucleocapsid [5,7].
In other words, virus-endosome fusion and capsid release into the
cytosol could be spatially and temporally separated. The
asynchronous and often rate-limiting steps of virus internalization
and trafficking hamper the studies of endosomal fusion and its
regulation. In order to gain mechanistic insights into the virus-
endosome fusion, it is essential to isolate the virus fusion step from
the upstream asynchronous processes and to control the timing of
low pH exposure and acidity of endosomal compartments.
Avian Sarcoma and Leukosis virus (ASLV) initiates fusion via a
two-step mechanism that involves priming of Env glycoprotein by
cognate receptors (presumably on the cell surface) and low pH-
dependent fusion with endosomes [3,10–12]. The receptor
priming of Env confers the competence for acid-mediated
refolding that drives the merger of viral and endosomal
membranes. Subtype A ASLV infects cells expressing either of
the alternative isoforms of the TVA receptor, TVA800 and
TVA950, which reside in lipid rafts and liquid-disordered
domains, respectively [13–15]. Importantly, the transmembrane
(TVA950) and GPI-anchored (TVA800) isoforms appear to direct
the virus entry through distinct endocytic pathways [16]. ASLV
fuses more efficiently with TVA950-expressing than with
TVA800-expressing cells [17]. Considering that these isoforms
have identical ectodomains [13,14] and exhibit a similar
glycosylation pattern (data not shown), the difference in fusion
efficiency is likely due to the properties of sub-cellular compart-
ments harboring the virus at the time of fusion. A critical feature of
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neutral pH [11,16,18], which enables the virus to survive the
prolonged fusion block imposed upon raising the endosomal pH
by NH4Cl. Removal of NH4Cl after several hours of incubation
restores acidic conditions and quickly initiates infection [16]. This
arrest/release protocol thus allows one to isolate virus-endosome
fusion from the preceding internalization and trafficking steps
[16,17].
Here, we employed the NH4Cl arrest/release protocol to
synchronize the ASLV fusion. Removal of weak base resulted in
an immediate and uniform pH drop in all intracellular compart-
ments, thus standardizing the fusion trigger. Synchronized fusion
facilitated the detection of viral core release from an endosome as
a result of full enlargement of the fusion pore. We defined the sites
of core release in cells expressing alternative receptors by (i)
measuring the mobility of sub-viral particles after spatial separa-
tion from endosomes and (ii) probing the dynamics of pH changes
within the recipient compartments upon removal of NH4Cl. These
experiments showed that the viral cores were released into the
cytosol of TVA950 cells. By contrast, the cores were delivered into
endosomal compartments of TVA800 cells, from which they
entered into the cytoplasm after an additional slow temperature-
dependent step. Our findings imply that ASLV fusion is redirected
to distinct intracellular compartments of cells expressing alterna-
tive receptors in the presence of NH4Cl. This approach provides
new insights into the morphology and fusion-permissiveness of
these compartments.
Results
Rationale
Removal of ammonium chloride results in acidification of all
intracellular compartments, including the cytoplasm [19]. This
effect is due to protons left behind by NH4
+, which traverses a
membrane in its neutral NH3 form (Figure S1A). Here, we
synchronized ASLV fusion by allowing virus internalization in the
presence of NH4Cl followed by removal of the fusion block. A
quick drop of endosomal pH caused by the NH4Cl removal thus
serves as a standardized trigger for ASLV-endosome fusion,
irrespective of the distinct trafficking itineraries for this virus
through TVA800 and TVA950 isoforms [16,17]. This ‘‘on
demand’’ ASLV fusion with endosomal compartments offers
several advantages for single particle imaging, since it (i) bypasses
the slow pre-fusion steps and likely allows optimal priming of Env
by receptors; (ii) eliminates the differences in the pH within distinct
intracellular compartments; and (iii) simplifies virus tracking. In
addition, the NH4Cl arrest redirects the virus entry to distinct
intracellular compartments thus providing an opportunity to
probe their relative permissiveness to viral fusion. As we will show
below, although NH4Cl impairs endosomal trafficking and
maturation [20–22], these conditions provide valuable information
regarding viral fusion with alternative sub-cellular sites and
elucidate early post-fusion steps.
Removal of NH4Cl causes quick and uniform acidification
of all intracellular compartments
We first assessed the effect of NH4Cl removal on endosomal pH
by loading intracellular compartments with the endosomal pH
indicator, pHrodo dextran [23]. In the presence of weak base, the
endosomal pH exhibited a fairly narrow distribution around a
neutral value (Figure S1B). Immediately after NH4Cl removal by
local perfusion with Hank’s buffer (HBSS), the endosomes became
uniformly acidic (Figure S1B, C).
We next measured the pH changes within virus-carrying
endosomes by co-labeling the viral envelope with the GFP-
ICAM-1 chimera [17] and the membrane dye, DiD. Viral
particles were identified based on the interior marker, MLV Gag-
mKO [24]. Triple-labeled pseudoviruses were internalized by cells
upon incubation in the presence of NH4Cl. Since the majority of
ASLV is internalized by CV-1-derived target cells within 40 min
[17], we choose this time interval for NH4Cl pretreatment.
Acidification of endosomal lumen upon removal of NH4Cl
quenched the GFP fluorescence (pKa 6.15 [25]), while the pH-
independent DiD probe served as a reference signal for the
ratiometric pH measurements (Figure S1D-F). We found that
endosomal pH exponentially decayed throughout the 2 min-
perfusion with HBSS reaching 5.760.3 (n=20) in both TVA800
and TVA950 cells at the end of the pulse (Figure S2A).
In parallel experiments, the changes in the cytosolic pH were
monitored by labeling the membrane of GFP-transfected CV-1
cells with DiD and measuring the ratio of the intracellular GFP
and DiD fluorescence upon addition/removal of NH4Cl. As
shown in Figure S2B, the cytosolic pH dropped to ,6.8 at the
beginning of HBSS perfusion, but nearly completely recovered
before the cells were returned to NH4Cl. This likely occurs as a
result of compensatory mechanisms that effectively raise the
intracellular pH [19,26,27]. To conclude, the NH4Cl arrest/
release protocol results in quick and uniform acidification of
endosomes and the cytosol. This feature is essential for inducing
fusion of internalized ASLV irrespective of the identity of virus-
bearing endosomes in TVA800 and TVA950 cells.
ASLV fuses synchronously with endosomes upon lifting
the NH4Cl block
We have previously shown that labeling of pseudoviruses with
MLV Gag-GFP permits visualization of single virus fusion in live
cells [17]. Gag-GFP is cleaved into defined fragments upon virus
maturation, including the GFP-tagged nucleocapsid protein. This
fragment is loosely trapped within mature viruses and is readily
released upon permeabilization of the viral membrane or as a
result of fusion [28]. Our single virus fusion assay is thus based on
the loss of GFP content from a viral particle. By contrast, the
Author Summary
Endosomal trafficking and regulation of retrovirus fusion is
poorly understood, due in part to heterogeneity of viral
particles and their asynchronous entry into an endocytic
pathway. Here, we used an avian retrovirus that enters
host cells in a receptor- and low pH-dependent manner.
This feature allowed capturing the virus in intracellular
compartments through raising the endosomal pH. Virus
fusion was synchronously initiated upon permitting
endosome acidification and visualized in real-time by
single particle imaging. We found that different receptor
isoforms directed virus into distinct sub-cellular compart-
ments supporting quick release of the viral core. Through
tracking individual sub-viral particles released from endo-
somes, we found that the full length receptor mediated
core delivery into the cytoplasm. By contrast, fusion
mediated by the GPI-anchored receptor released the core
into another endosomal compartment, from which the
core entered the cytosol through an additional tempera-
ture-dependent step. These findings demonstrate different
permissiveness of endosomal compartments to viral fusion
and the existence of a post-fusion step leading to the
cytosolic release of cores and initiation of infection.
Imaging of Virus Fusion and Core Release
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redistribution into an endosomal membrane and thus retains its
punctate appearance [17,29].
To synchronize the ASLV fusion, Gag-GFP and DiD labeled
pseudoviruses were pre-bound to target cells in the cold and
incubated at 37uC in the presence of NH4Cl. Cells were mounted
on a heated microscope stage and imaged in an NH4Cl-containing
buffer for a short period of time before removing the fusion block
by perfusion with HBSS. Internalized ASLV particles that failed to
undergo fusion with endosomes following the NH4Cl arrest/
release protocol exhibited reversible GFP quenching-dequenching
pattern (Figure 1A–C, and video S1) reflecting changes in the
intraviral pH (Figure S2C). Three types of fusion-related events
were induced by the arrest/release protocol in either TVA950 or
TVA800 cells (Table 1). First, nearly 20% of virions fully released
their content as a result of fusion (Figure 1D, E and video S2).
Second, about the same fraction of viruses partially lost their
content marker (Figure 1F, G). A partial loss of viral content could
be due to incomplete cleavage of the Gag-GFP precursor, which
would remain in large oligomeric complexes, unable to permeate
through a small fusion pore. Consistent with this notion, a similar
fraction of viruses (around 20%) exhibited a partial loss of the GFP
marker following the saponin-mediated lysis (Figure S3). Third, we
observed a combination of a partial GFP release with subsequent
separation of the GFP-tagged core from the viral/endosomal
membrane labeled with DiD (Table 1 and Figure 1A, double
arrowhead).
Irrespective of the TVA isoform, all three fusion-related events
collectively accounted for ,50% of viruses internalized in the
presence of NH4Cl (Table 1). By comparison, 16% and 4% of
viruses fused with TVA950 and TVA800 cells, respectively,
through conventional entry in the absence of NH4Cl [17]. Thus,
the arrest/release protocol markedly enhanced the efficiency of
ASLV fusion, especially with TVA800 cells. The enhancing effect
was likely due to several factors, including the quick acidification of
endosomal lumen, and the ease of detection of synchronous fusion
events within arrested endosomes. More importantly, the mark-
edly improved probability of fusion could be due to a higher
fusion-permissiveness of endosomes harboring the virus in the
presence of NH4Cl compared to sites of uninterrupted ASLV
fusion.
Synchronous initiation of ASLV fusion allows detection of
early post-fusion events
As shown above, ,20% of pseudoviruses released only a
fraction of their GFP marker as a result of fusion (Figure 1F, G).
This was likely due to a partial cleavage of Gag-GFP during virus
maturation. The presence of particles that contained both a
releasable GFP maker and uncleaved Gag-GFP provides an
opportunity to monitor the formation and enlargement of Env-
mediated fusion pores, respectively. Indeed, a sizeable fraction of
events were manifested in a diminution of the GFP signal upon
perfusion with HBSS/NH4Cl followed by spatial separation of
green and red puncta (Figures 1A and 2A). These events occurred
with similar frequencies in TVA950 and TVA800 cells: 13.965%
(n=87) and 12.365% (n=86), respectively (Table 1). Upon
separation from endosomes, which retained the viral DiD marker,
GFP-tagged puncta exhibited accelerated motion and traveled as
one entity without losing fluorescence intensity (Figure 2, trajec-
tories shown below the graphs, and videos S3 and S4). These
results further support the notion that green puncta are sub-viral
particles (SVPs) containing unprocessed Gag-GFP. We analyzed
the spatial separation events by tracking the GFP-labeled particles.
The moment of spatial separation was defined based on the loss of
the DiD signal which was initially co-localized with the GFP signal
(Figure 2, blue asterisks).
In contrast to the synchronized ASLV fusion, we very rarely
observed spatial separation of core and membrane markers after a
partial loss of a diffusible content marker upon the virus entry
through a conventional route. This is likely due to the delayed
release of the viral core, which could not be reliably detected
because of the loss of the DiD signal (data not shown). The
disappearance of DiD marker after redistribution to an endosome
probably occurs through its trafficking out of an endosome
[17,29]. The lack of detectable capsid release through uninter-
rupted ASLV entry suggests that Env-mediated fusion pores
enlarge slowly, so the capsids are released at later times after
trafficking to different compartments. It appears that, in the
presence of NH4Cl, ASLV is redirected to endosomes that support
quick pore enlargement and core release.
The rate of fusion pore dilation depends on the receptor
isoform
Regardless of whether or not the released SVPs corresponded to
the bona fide viral capsid or to large oligomeric Gag-GFP
complexes, their liberation signifies pore dilation and can thus
be used to study this final step of fusion. Similar probabilities of the
pore formation (loss of diffusible GFP) and release of SVPs in cells
expressing TVA800 and TVA950 (,13%, Table 1) indicate that,
under our conditions, both receptor isoforms support equally
efficient pore enlargement. We then asked whether the rate of pore
enlargement was also independent of the receptor isoform. The
time course of pore dilation was deduced from the lag between the
onset of HBSS perfusion, which quickly triggered the pore
opening, and spatial separation of SVPs from endosomes, as
determined by the loss of the DiD signal from double-labeled
particles (Figure 2B and C (blue asterisks), and videos S3 and S4,
respectively). The obtained lag times between the onset of HBSS
perfusion and SVP release were plotted as cumulative probabilities
over time (Figure 2D). This analysis revealed that the SVPs were
released (and thus the pore enlarged) faster in TVA950 cells
compared to cells expressing the GPI-anchored receptor. Approx-
imately 83% of these events were detected within the 2 min
window of HBSS perfusion for TVA950 cells, whereas only 40%
of cores were released into TVA800 cells within this interval.
Together, our results imply that, whereas the arrest/release
protocol promotes efficient opening and expansion of fusion pores
in cells expressing either receptor isoform, the apparent rate of
pore dilation is faster in TVA950 cells (Figure 2D). The more
efficient dilation of pores formed in TVA950 cells compared to
TVA800 cells is consistent with our previous observation that early
fusion pores formed by ASLV are larger in cells expressing
TVA950 compared to TVA800 under normal entry conditions
[17]. While dissociation of the viral core from the membrane could
itself be a slow process [30], the receptor isoform-dependence of
the release kinetics argues against this possibility. On the other
hand, we sometimes detected incomplete separation of GFP-
tagged sub-viral particles from the viral membrane which could be
due to partial pore dilation (Figure S4).
TVA isoforms mediate release of viral cores into distinct
subcellular compartments
Next we sought to define the cellular compartments into which
the SVPs were released. We reasoned that the formation/
enlargement of a fusion pore between the virus and the limiting
membrane of an endosome should bring the intraviral pH to that
of the cytosol. Since the cytosolic and endosomal/intraviral pH
Imaging of Virus Fusion and Core Release
PLoS Pathogens | www.plospathogens.org 3 May 2012 | Volume 8 | Issue 5 | e1002694Figure 1. Arrest and synchronous triggering of ASLV pseudovirus fusion with endosomes using NH4Cl. (A) Micrograph showing single
ASLV pseudoviruses co-labeled with Gag-GFP (green) and DiD (red) following the incubation with cells expressing TVA800 for 40 min at 37uCi n
isotonic HBSS supplemented with 70 mM NH4Cl (left panel). Removal of NH4Cl through perfusion with HBSS caused a marked decrease in the GFP
signal, but not in DiD fluorescence (middle). Upon returning to NH4Cl (right), the GFP fluorescence of fusion-incompetent particles fully recovered
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(Figure S2), the formation of a fusion pore with the limiting
membrane of an endosome is expected to raise the intraviral pH.
By contrast, if released cores remain inside an endosome (see
Discussion for the model), the core-associated GFP will be exposed
to a continuously dropping pH throughout the HBSS pulse
(Figure 1B, C, pink lines).
We found that SVPs released into TVA950 cells during the
HBSS perfusion typically exhibited pH responses that were
consistent with their release into the cytosol. The GFP signal
initially dropped due to the acid-mediated quenching and the
release of a diffusible fraction of this marker. However, green
fluorescence partially recovered before the end of HBSS perfusion
(Figure 2B, pink lines), in spite of the continued decrease of
endosomal pH (Figures 2C, pink line, and S2A). The partial
recovery of the GFP fluorescence occurred at the time or soon
after spatial separation from an endosome and paralleled the
increase in cytosolic pH (Figure 2B, video S3). These results imply
that SVPs are released into the cytosol of TVA950 cells. In sharp
contrast, spatial separation events in TVA800 cells were not
accompanied by recovery of the GFP signal during the HBSS
pulse (Figure 2C, videoS4), consistent with the continuous drop of
endosomal pH (pink line). Fluorescence partially recovered only
after returning to NH4Cl. This pattern was observed for nearly all
spatial separation events in TVA800 cells (n=18, see also Figures
S5 and S6), suggesting that cores entered intracellular compart-
ments distinct from the cytoplasm. It is worth pointing out that
SVPs were not always released into the cytosol of TVA950 cells: in
3 out of 14 spatial separation events the GFP fluorescence decayed
monotonously throughout the HBSS perfusion and partially
recovered only after returning to NH4Cl (exemplified in Figure
S7). In other words, the ASLV fusion in NH4Cl-arrested TVA950
cells did not uniformly result in the viral content release into the
cytosol.
As shown in Figure 2D, a fraction of SPVs were released after
the end of the HBSS pulse. Since these delayed events took place
under conditions when pH in all intracellular compartments was
raised to neutrality by NH4Cl, the sites of core release could not be
unambiguously established. To address this issue, a second HBSS
pulse was applied. During the second pulse, the signal from SVPs
in TVA950 cells exhibited a biphasic behavior similar to that of
the cytosolic pH (Figure 2E, n=11), which was consistent with the
delivery of viral cores into cytoplasm. By comparison, the GFP
signal from the late SVPs release events in TVA800 cells remained
quenched throughout HBSS perfusion and increased only after
returning to NH4Cl (Figure 2F, n=6). Collectively, our results
indicate that, in cells expressing the GPI-anchored TVA isoform,
ASLV Env mediates the release of SPVs into compartments that
lack the active buffering capacity of the cytoplasm.
Viral cores that entered an endosome are expected to be
restricted in their motion. We therefore compared the motion
patterns of the newly release SVPs in cells expressing alternative
receptor isoforms. We found that motion of virus-carrying
endosomes in NH4Cl-arrested cells was restricted, as evidenced
by a shallow slope of the mean square displacement (MSD) over
time (Figure 3A, B, red circles). However, coincident with the time
of spatial separation (blue asterisks), the initial MSD slope for
green puncta drastically increased (Figure 3A, B, green circles),
whereas the movement of DiD-positive puncta (host endosome)
continued to be restricted. For the liberated SVPs, the average
slopes of log(MSD) vs. log(time) were 0.9860.003 and 0.8060.01
(n=15) in TVA950 and TVA800 cells, respectively (Figure 3C,
D). The MSD slopes close to 1 are indicative of free diffusion of
SVPs released as a result of fusion [31].
To further characterize the motion patterns of these particles,
we calculated the effective diffusion coefficients (D) from the MSD
plots for endosomes, viruses trapped in endosomes, and for
liberated sub-viral particles. This analysis confirmed that endo-
somes and viruses residing within endosomes tended to move
slowly (typical D below 0.1 mm
2/sec, Figure 3E, in accordance to
[32]). Only a fraction of Rab5-positive endosomes exhibited
significant mobility. In contrast to endosomes, released SVPs were
relatively more mobile. Interestingly, SVPs in TVA950 cells
moved nearly twice as fast as in TVA800 cells: D=0.3060.1
(n=20) and 0.1660.09 mm
2/sec (n=20), respectively (P,0.0005).
The fact that movement of SVPs released into TVA800 cells was
more restricted than in TVA950 cells is consistent with delivery of
these particles into endosomal compartments. Analysis of individ-
ual particle trajectories confirmed this finding (Figures S5 and S6).
On the other hand, a few SVPs that did not exhibit changes in the
GFP signal paralleling the pH changes in the cytosol of TVA950
cells (e.g., Figure S7) also moved slowly, consistent with their
(#1, arrowhead), whereas the signal from fused particles remained undetectable (#2, arrow). The viral core release into the cytosol is manifested in
spatial separation of green and red puncta (#3, double arrowhead). Cell nuclei are labeled with Hoescht (blue). Scale bar is 15 mm. (B–G) ASLV
pseudoviruses co-labeled with Gag-GFP and DiD were internalized by CV-1 cells expressing TVA950 (B, D, F) or TVA800 (C, E, G) in the presence of
NH4Cl, and virus-endosome fusion was initiated by perfusion with HBSS, as described in Materials and Methods. (B, C) The fluorescence intensity
profiles corresponding to particles that failed to fuse following the arrest/release protocol, as evidenced by complete recovery of the GFP signal. (D, E)
Examples of complete loss of the GFP marker from virions. (F, G) Partial release of the content marker. Cells were initially perfused with 70 mM NH4Cl
in HBSS (white thick horizontal bars at the top of each graph) followed by perfusion with plain HBSS for 2 min (black horizontal bars) and returned to
NH4Cl. The mean intensities of GFP and DiD fluorescence from single particles are shown (green and red circles, respectively). Pink lines show the
changes in the intraviral pH upon removal of NH4Cl (for details, see Figures. S1 and S2). Kymographs illustrating the time-dependent changes in the
mean GFP and DID signals (overlaid) are also shown above each plot. An irreversible transition from yellow (co-localized GFP and DiD signals) to red
(DiD only) manifests the release of the GFP-based content marker into the cytosol. Diagrams of the fusion outcomes (reversible GFP quenching by
acidic pH, full and partial release of the content marker) for respective panels are shown on the right.
doi:10.1371/journal.ppat.1002694.g001
Table 1. Outcomes of synchronized ASLV-endosome fusion.
Full release Partial Release Core release No fusion
TVA800 cells (n=91) 18.7% 26.3% 12.1% 42.9%
TVA950 cells (n=90) 18.6% 19.8% 13.2% 48.4%
The relative frequency of fusion outcomes was determined by pooling data from at least 4 independent experiments.
doi:10.1371/journal.ppat.1002694.t001
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PLoS Pathogens | www.plospathogens.org 5 May 2012 | Volume 8 | Issue 5 | e1002694Figure 2. Spatial separation of the GFP-tagged viral cores from membranes as a result of fusion. (A) Spatial separation of the GFP- and
DiD-tagged puncta following the NH4Cl arrest/release protocol. Double-labeled viruses were internalized by TVA950 (top panel) and TVA800 (bottom
panel) cells in the presence of NH4Cl. Fusion was triggered by replacing NH4Cl with HBSS for 2 min (black horizontal bars) through local perfusion,
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single particle tracking further supported our conclusion that viral
cores were released into distinct compartments within the NH4Cl-
arrested TVA800 and TVA950 cells.
Viruses internalized through TVA isoforms in the
presence of NH4Cl are trapped within different
endosomes
How could the apparent lack of SVP release into the cytoplasm
of TVA800 cells be rationalized? Putative compartments harbor-
ing SVPs must be relatively large, as suggested by the disappear-
ance of the GFP signal occurring as a result of significant dilution
of the content marker. In agreement with this notion, in TVA800
cells the viral cores traveled considerable distances from
endosomes with which they fused. Within a few minutes after
SPV release the maximum distance between liberated SVPs and
the endosome of origin reached 4.961.7 mm (n=10) and
11.364.2 mm (n=10) in TVA800 and TVA950 cells, respectively.
The markedly different (P,0.001) separation of SVPs and
endosomes in these cells is another manifestation of the confined
core movement in TVA800 cells. These findings are thus in line
with the notion that SVPs are released into micron-size subcellular
compartments of NH4Cl-arrested TVA800 cells.
In order to test whether such unusually large compartments
exist in CV-1 cells expressing either receptor, we transiently
expressed markers for early (CFP-Rab5) and late (YFP-Rab7)
endosomes in TVA800 and TVA950 cells. Figure 4 shows that,
whereas these markers were not usually associated with large
endosomes in untreated cells, large circular compartments
reaching 3–4 mm in diameter became apparent in both cell lines
following pre-incubation with NH4Cl. Live cell imaging revealed
that large vacuoles started to form as early as after 10 min at 37uC
in the presence of NH4Cl (data not shown). It is therefore possible
that small ASLV-carrying endosomes are somehow delivered into
these abnormally large compartments in NH4Cl-arrested
TVA800, but not in TVA950 cells.
To further test the possibility that ASLV is trafficked to different
compartments of the two cell lines, we analyzed the virus co-
localization with markers of early and late endosomes. Arresting
the ASLV fusion by NH4Cl greatly simplifies this analysis, since
viruses accumulate in distinct intracellular compartments in cells
expressing alternative receptor isoforms. Cells were co-transfected
with CFP-Rab5 and YFP-Rab7 and allowed to internalize
pseudoviruses labeled with Gag-mKate2 (red) for 40 min in the
presence of NH4Cl. Co-localization analysis revealed that 82% of
ASLV pseudoviruses resided in Rab5-positive and mixed Rab5/
Rab7-positive compartments in TVA950 cells (Figure 5A, C). In
contrast, the majority (63%) of viruses internalized through
TVA800 co-localized with Rab7 and only 25% were found in
Rab5-positive endosomes (Figure 5B, C).
We also examined the spatial overlap between synchronized
ASLV fusion and endosomal markers. ASLV fused with Rab5-
positive endosomes of both TVA800 and TVA950 cells (e.g.,
Figure S8). However, dynamic co-localization analysis of fusion
with Rab7-positive compartments could not be reliably performed
because of their clustering at the perinuclear space of NH4Cl-
arrested cells (Figure 5). We therefore chose not to pursue these
experiments. Taken together, the above results support the notion
that the two receptor isoforms traffic ASLV into distinct
intracellular compartments. Since the NH4Cl arrest-release
protocol leads to efficient infection of cells expressing TVA800
([16] and data not shown), viral cores must eventually enter into
the cytoplasm. The post-fusion steps resulting in capsid liberation
into the cytoplasm are addressed below.
Sub-viral particles released into TVA800 cells reach the
cytosol after an additional slow temperature-dependent
step
If SVPs are released into endosomal compartments of TVA800
cells, an additional step would be required to deliver these particles
into the cytoplasm and establish productive infection (assuming
that SVPs represent bona fide viral cores). To address this question,
we pseudotyped the HIV-1 core carrying the beta-lactamase
(BlaM) reporter enzyme with the ASLV Env and used these
particles to measure virus-cell fusion [29,33]. Transfer of the viral
core-incorporated BlaM into the cytosol as a result of fusion allows
cleavage of a fluorogenic substrate sequestered in the cytoplasm.
This substrate is thus inaccessible to the BlaM trapped within the
viral particles that fail to fuse.
ASLV pseudoviruses were internalized by TVA800 or TVA950
cells for 45 min at 37uC in the presence of NH4Cl. Fusion was
initiated by transferring the cells into HBSS and was stopped after
varied times, either by chilling on ice (referred to as the
temperature block, TB) or by adding NH4Cl to re-neutralize the
endosomal pH (Figure 6A). Cells were loaded with the BlaM
substrate and incubated overnight at 12uC to allow the substrate
cleavage but prevent further fusion. When the NH4Cl block was
not lifted (t=0 for the chase experiment), only a background level
BlaM signal was detected (Figure 6). Consistent with our imaging
results, even a very brief removal of NH4Cl allowed fusion to
proceed to completion. Adding the NH4Cl back after a few
minutes no longer reduced the fusion efficiency in either cell line
(Figure 6B, C). Similarly, the TB applied even after a brief removal
of NH4Cl failed to block fusion in TVA950 cells (Figure 6B). In
and cells were returned to NH4Cl. Following the initial decay in the GFP fluorescence due to a partial release of the content marker, co-labeled
particles split in two and continued to drift apart. The GFP signal partially recovered during the HBSS perfusion in TVA950 cells, but not TVA800 cells
where recovery occurred only after returning to NH4Cl. Scale bar is 0.15 mm. (B, C) Separation of green (Gag-GFP) and red (DiD) puncta in NH4Cl-
arrested TVA950 (B, video S3) and TVA800 (C, video S4) cells during perfusion with HBSS. The graphs show changes of the mean intensity of green
and red signals for single particles shown in panel A. A drop in the red signal during the HBSS perfusion (marked by a blue asterisk) occurs due to the
separation of formerly co-localized red and green puncta. The changes in cytosolic (B, E) and endosomal (C, F) pH during the HBSS perfusion
measured in separate experiments (for details, see Figure S2) are shown by pink lines. (D) Kinetics of spatial separation of SVPs and the viral
membrane triggered by a 2 min-perfusion with HBSS (black horizontal bar and vertical dashed lines). Cumulative probabilities of core release as a
function of time are plotted for TVA800 (filled circles) and TVA950 (open circles) cells. (E, F) Late spatial separation events occurring at the end or after
the first HBSS pulse (horizontal black bars above each plot). The SVP release in a TVA950 cell (E, asterisk) was followed by partial recovery of the Gag-
GFP fluorescence during the second HBSS perfusion, which paralleled the increase in the cytosolic pH (pink line). A spike in the DiD signal at the
beginning of the second HBSS pulse in panel D occurred due to a transient overlap between separated puncta. The late SVP release events in TVA800
cells (F) did not exhibit the Gag-GFP signal recovery in the course of HBSS perfusion. The two-dimensional trajectories of the recipient endosomes
(red) and the GFP-tagged sub-viral particles (green) obtained by single particle tracking are shown under for each respective panel. The beginning
and the end of trajectories are marked by triangles and circles, respectively. A diagram showing the viral content and core release (spatial separation
from the membrane) as a result of fusion are shown on the right.
doi:10.1371/journal.ppat.1002694.g002
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PLoS Pathogens | www.plospathogens.org 7 May 2012 | Volume 8 | Issue 5 | e1002694Figure 3. Sub-viral particles released by ASLV-endosome fusion exhibit increased mobility. (A, B) Examples of the mean square
displacement (MSD) as a function of time for GFP-tagged (green circles) and DiD-tagged (red circles) particles in TVA950 (A) and TVA800 (B) cells. Blue
asterisks mark spatial separation of cores from membranes that coincided with an abrupt increase in the MSD slope for SVPs (green), while the
movement pattern of DiD-recipient endosomes did not change significantly. (C) Representative MSD curves after SVP release are shown for five SVPs
in TVA950 cells (black lines) and in TVA800 cells (red lines). (D) Log-log plot showing the mean MSD slopes and standard deviations for 15 SVP
trajectories after core release in TVA950 (black) and TVA800 (red) cells each. (E) Distributions of diffusion coefficients for endosomes and viral particles
before and after SVP release. Diffusion coefficients were calculated, as detailed in the Materials and Methods. Box plots together with the Gaussian
distribution for the diffusion values (circles and solid lines) corresponding to 18 endosomes (‘‘DiD post-fusion’’, red circles) and SVPs (‘‘GFP post-
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NH4Cl block was markedly delayed in TVA800 cells (Figure 6C).
This delayed resistance to low temperature that occurred with
half-time ,20 min was suggestive of an additional post-fusion step
responsible for delivery of viral cores into the cytosol. It is thus
conceivable that SVPs are first released into intracellular
compartments in NH4Cl-arrested TVA800 cells and then enter
into the cytosol through an additional Env-independent, temper-
ature-dependent step.
Discussion
We have previously found that ASLV fuses far less optimally with
TVA800 cells compared to TVA950 cells when entering via a
conventional route [17]. Because these receptor isoforms have
identical ectodomains, it is unlikely that their Env binding or
priming activities differ considerably. On the other hand, a recent
study using cells expressing undetectably low levels of TVA800 and
TVA950 arrived to the conclusion that more than one GPI-
anchored receptor is required for ASLV infection, whereas a single
transmembrane receptor is sufficient for productive entry [34].
However, this finding does not rule out the possibility that post-
priming steps of entry determine the ASLV fusion efficiency and
thus the minimal number of receptors supporting this process. We
favor the model that the higher probability of fusion with TVA950
cells is due to ASLV trafficking to more permissive compartments
than those in TVA800 cells [17]. This notion is consistent with data
supporting ASLV trafficking to distinct intracellular compartments
in cells expressing alternative TVA isoforms [16,17]. The differ-
ences in fusion-permissiveness of distinct endosomes suggest a role
for host factors in regulating ASLV fusion and capsid release.
Although NH4Cl impairs endosomal trafficking [20–22], the
arrest/release protocol employed in this study provides an
unprecedented opportunity to redirect the ASLV fusion to
different compartments and study this process under controlled
conditions. This approach permitted: (i) synchronous and uniform
acidification of all endosomes harboring the virus; (ii) isolation of
low pH-dependent stages of fusion from upstream receptor-
priming and virus trafficking; and (iii) enhancement of the viral
core release from endosomes. A uniform acid load delivered upon
NH4Cl removal allowed us to meaningfully compare the fusion-
permissiveness of endosomes harboring the virus and to infer their
overall topology. In summary, the NH4Cl block applied to cells
expressing alternative TVA isoforms provided a critical means to
direct the ASLV entry through distinct endosomes and gain new
insights into early post-fusion processes. We are currently working
on visualization of the viral core release upon uninterrupted ASLV
entry through alternative TVA isoforms.
Novel approaches introduced in this study enabled probing the
sites of ASLV fusion. As a rule, sub-viral particles liberated in
NH4Cl-arrested TVA950 cells sensed the cytosolic pH, consistent
with the ASLV fusion with the limiting membrane of an endosome
(Figure 7). In contrast, cores released into TVA800 cells
experienced the pH responses characteristic of endosomal
compartments lacking the active buffering ability of the cytosol.
Subsequent core release into the cytosol was detected by the BlaM
assay (Figure 6). The nature of this slow temperature-dependent
post-fusion step is presently unknown. We propose the following
two-step model for ASLV fusion with TVA800 cells following the
NH4Cl arrest/release protocol.
Since the viral membrane marker does not spread over a larger
area as a result of fusion, it is likely that ASLV fuses with a small
intralumenal vesicle. However, to account for disappearance of the
viral content marker through a marked dilution for increased
mobility of the released core, virus has to reside within a small
vesicle (Figure 7). We propose that a small virus-carrying vesicle is
in turn enclosed by a large intralumenal vesicle within an
endosome. Multilamellar endosomes have been observed under
physiological conditions and in the presence of NH4Cl [21,35–37].
This triple-vesicle enclosure is based on several considerations.
First, the interior of an intralumenal vesicle is topologically
equivalent to the cytoplasm, so that internalized virus cannot
reside within that vesicle. Second, core liberation into the cytosol
from the remaining double membrane enclosure can occur
through back-fusion [5] (Figure 7), consistent with a slow
temperature-dependent step following the low pH-mediated fusion
with TVA800 cells (Figure 6).
The proposed ASLV entry pathway is somewhat similar to that
postulated for the Vesicular Stomatitis Virus (VSV). VSV is
thought to fuse ‘‘laterally’’ with an intralumenal vesicle (Figure 7,
question mark) and release its capsid through back-fusion with the
limiting membrane of a late endosome [5] (but see [38] for an
opposite view). Our experimental data are difficult to reconcile
with the VSV model. First, as pointed out above, fusion with small
intralumenal vesicles should not result in sufficient dilution of the
viral content to account for disappearance of the GFP signal
(Figure 7). Second, the capsid release into a small vesicle will not
allow detectable spatial separation from the viral envelope. Third,
back-fusion of virus/vesicle hybrids should spill the viral mem-
brane marker into a large area of the endosome’s limiting
membrane, an event that has been observed only once in our
experiments (data not shown). We therefore favor the ‘‘triple-
enclosure’’ model presented above. It would be interesting to
elucidate trafficking processes that entrapped the virus within such
structure.
Results presented in this study revealed the previously
unappreciated aspects of viral entry through distinct pathways.
Synchronous triggering and real-time visualization of ASLV fusion
in cells expressing alternative receptors demonstrates that the
identity of virus-harboring compartments determines the efficiency
of fusion. Furthermore, the viral core release in NH4Cl-arrested
TVA800 cells proceeds through a complex pathway that involves
sequential pH-dependent and temperature-dependent steps. The
latter post-fusion step(s) is unlikely to be mediated by ASLV Env.
This provides strong evidence for the existence of back-fusion,
which has been implicated in entry of several viruses [5,7] and of
the anthrax toxin lethal factor [39]. Novel tools developed in this
study can be used for probing the sites of fusion and capsid release
of other viruses and to gain insights into vesicular trafficking and
cargo sorting processes.
Materials and Methods
Cell lines, viruses and reagents
African green monkey kidney CV-1 and human embryonic
kidney HEK293T/17 cell lines were obtained from ATCC
fusion’’, green circles) after core release are shown for TVA800 and TVA950 cells. Diffusion coefficients of three SVPs that were judged to be released
into endosomal compartments of TVA950 cells are colored black (under ‘‘GFP post-fusion’’). For comparison, the motility of 10 non-fusogenic
particles trapped in endosomes after perfusion with HBSS is shown (‘‘GFP, no fusion’’, yellow circles). In addition, the diffusion coefficients for 10 not
fused particles in the presence of the inhibitory peptide R99 is shown (blue circles). The diffusion coefficients of endosomes tagged with YFP-Rab7
(n=20) and CFP-Rab5 (n=20) in TVA800 and TVA950 cells (pooled data) are shown by magenta and cyan triangles, respectively.
doi:10.1371/journal.ppat.1002694.g003
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CD4, CXCR4 and CCR5 (donated by Drs. J.C. Kappes and X.
Wu [40] were obtained from the NIH AIDS Research and
Reference Reagent Program. CV-1-derived CV-1/TVA800 and
CV-1/TVA950 cells expressing high levels of alternative TVA
receptors have been described previously [17]. TZM-bl cells
expressing TVA800 or TVA950 were obtained by transduction
with VSV-G pseudotyped retroviral vectors pCMMP-TVA950 or
pCMMP-TVA800, as described previously [16]. Cells expressing
high levels of either TVA receptor were sorted by flow cytometry
using a FACS Aria II (BD Biosciences, San Jose, CA) after binding
to the subgroup A ASLV SU-IgG fusion protein [16] and a goat
anti-rabbit FITC-conjugated secondary antibody (Sigma, St.
Louis, MO). CV-1-derived cells were grown in Dulbecco’s
Figure 4. NH4Cl arrest creates large endosomes. (A) TVA950 cells co-expressing CFP-Rab5 (green) and YFP-Rab7 (red) before (top row) and after
(bottom row) incubation with 70 mM NH4Cl for 40 minutes at 37uC. Enlarged endosomes positive for Rab5 (diameter 12 mm) and Rab7 (diameter
15 mm) are indicated by arrowheads and arrows, respectively. Scale bars are 20 mm. (B) Same as in panel A, but for TVA800 cells. Enlarged endosomes
positive for Rab5 (diameter 3.5 mm) and Rab7 (diameter 5 mm) are indicated by arrowheads and arrows, respectively. Scale bar 15 mm.
doi:10.1371/journal.ppat.1002694.g004
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PLoS Pathogens | www.plospathogens.org 10 May 2012 | Volume 8 | Issue 5 | e1002694Figure 5. NH4Cl-arrested ASLV preferentially resides in Rab5-positive endosomes in TVA950 cells and in Rab7-positive
compartments in TVA800 cells. Cells co-transfected with CFP-Rab5 (cyan) and YFP-Rab7 (green) were allowed to internalize ASLV pseudoviruses
labeled with Gag-mKate2 (red) for 40 minutes at 37uC in the presence of 70 mM NH4Cl. (A) Image projections obtained from 30 confocal slices show
viruses in a TVA950 cell expressing CFP-Rab5 and YFP-Rab7. Arrowheads show viral particles co-localized with Rab5-positive puncta. A rectangular
region of interest, R0I (1069 mm) encompassing a viral particle (upper left panel) is enlarged and shown in the lower panel. ROI is a confocal slice
corresponding to the maximum intensity in Z for the red channel (Gag-mKate2). (B) Same as in panel A, but for TVA800 cell co-transfected with CFP-
Rab5 and YFP-Rab7. Arrowheads show viral particles co-localized with Rab7-positive endosomes. A blow up view of ROI encompassing an
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VA) supplemented with 10% Cosmic Calf Serum (HyClone
Laboratories, Logan, UT) and 100 U penicillin-streptomycin
(Gemini Bio-Products, West Sacramento, CA). TZM-bl cells were
grown in high glucose DMEM supplemented with 10% Fetal
Bovine Serum (FBS, HyClone Laboratories, Logan, UT) and
100 U penicillin-streptomycin. HEK 293T/17 cells were main-
tained in high glucose DMEM supplemented with 10% FBS,
100 U penicillin/streptomycin and 0.5 mg/ml G418 sulfate.
The ASLV (subgroup A) Env-derived R99 peptide (,95%
purity by HPLC) was synthesized by Macromolecular Resources
(Fort Collins, CO). The lipophilic dye DiD (1,19-dioctadecyl-
3,3,39,39-tetramethylindodicarbocyanine, 4-chlorobenzenesulfo-
nate salt), Hoechst-33342 nuclear stain and pHrodo dextran were
purchased from Invitrogen (Carlsbad, CA). Ammonium chloride
was purchased from Sigma. Hank’s balanced salt solution with
calcium and magnesium without phenol red (HBSS) and
Phosphate-Buffered saline (PBS) were from Cellgro. Sodium
pyruvate was from Hyclone.
The subgroup A ASLV Env glycoprotein lacking the cytoplas-
mic domain (designated EnvDCT) has been described previously
[41]. The HIV-1 based packaging vector pR8DEnv lacking the env
internalized virus is shown in the lower panel. Co-localization analysis was done by constructing a line histogram (A and B, lower right panels) for a
chosen confocal plane that showed a maximum intensity for all channels (ROIs in A and B). The line histogram shows the changes in fluorescence
intensities for all three channels along the white lines (lower middle panels) drawn across the viruses and an endosomal compartment in the ROI
(1069 mm). Local maxima for Rab5 and/or Rab7 coinciding with the maximum of the mKate2 signal were counted as co-localization. Scale bars are
10 mm. (C) Summary of analyses of ASLV pseudovirus co-localization with endosomal markers in TVA950 (left) and TVA800 (right) cells.
doi:10.1371/journal.ppat.1002694.g005
Figure 6. ASLV progression through acid- and temperature-dependent steps of fusion after removal of the NH4Cl block. (A)
Schematic diagram of the NH4Cl arrest/chase experiments. EnvDCT/BlaM-Vpr pseudoviruses were bound to either TVA950 (B) or TVA800 (C) cells at
4uC. Cells were allowed to internalize virus during 45 min at 37uC in the presence of 70 mM NH4Cl (yellow line in A). Fusion was initiated by
transferring the cells into HBSS supplemented with 50 mg/ml R99 (blue line in A) for varied times and stopped either by adding back NH4Cl
containing 50 mg/ml R99 (black circles) or by placing the samples on ice (TB) (red circles). At the end of the chase, cells were chilled on ice, loaded
with the BlaM substrate and incubated overnight at 12uC. Data points are means and SEM of combined triplicate measurements from two
independent experiments.
doi:10.1371/journal.ppat.1002694.g006
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The pMM310 vector expressing BlaM-Vpr (donated by Dr. M.
Miller [42]) was obtained from the NIH AIDS Research and
Reference Reagent Program. Vectors expressing MLV Gag-pol,
Gag-GFP, MLV LTR lacZ, pECFP-C1-Rab5 and pEYFP-C1-
Rab7 [43] were a gift from Dr. W. Mothes (Yale University). The
MLV Gag-mKO expressing vector has been described previously
[24]. The mRFP-Rab5 and mRFP-Rab7 expression vectors were
obtained from Addgene (Cambridge, MA).
Construction of MLV Gag-mKate2 and GFP-ICAM-1
markers
The construction of GFP-ICAM-1 was done as follows. The
eGFP gene was amplified using KOD Xtreme DNA polymerase
(Novagen) and the following primers: 59-TAAGCTTCTCGAG
GTGAGCAAGGGCGAGGAGCTGTTC-39 (forward) and 59-
TGAATTCTT CTTGTACAGCTCGTCCATGCCGAGAGTG-
39 (reverse). The amplified fragment was cloned into pCR4blunt-
topo vectors using TOPO cloning kit (Invitrogen). After the
verification of the sequence of the gene of interest, the EcpH
sequence in the EcpH-ICAM-1 vector [29] was replaced with the
eGFP fragment using HindIII and EcoRI restriction sites (italicized
regions in the primer sequences). The pMLV-Gag-mKate2
plasmid was constructed by amplifying the mKate2 gene by
PCR using KOD Xtreme DNA polymerase (Novagen) and the
following forward and reverse primers: 59-ATTGCGGATCC-
GGCGGCGGTGGAGCTAGCGTGAGCGAGCTGATTAAGG-
AGAAC-39 and 59-TTCCGCCGGCTTAGATATCTCTGTGCC-
CCAGTTTGCTAGGGAG-39, which contained the BamHI and
NaeI restriction cleavage sites, respectively. The amplified fragment
was first clone into the pCR4blunt-topo vector, using TOPO
cloning kit (Invitrogen), and its sequence was verified. The YFP
gene in pMLV-Gag-YFP vector [44] was replaced with the
mKate2 sequence in pCR4blunt-topo by restriction digestion with
Figure 7. Model for ASLV fusion with cells expressing alternative receptors following the arrest/release protocol. Alternative receptor
isoforms direct ASLV entry through distinct pathways that culminate in fusion with early endosomes. Normal entry pathways through TVA800 and
TVA950 may converge to early endosomes where mildly acidic pH initiates the viral content release, albeit with different efficiency [17]. In the
presence of NH4Cl (gray arrows), the virus bypasses early endosomes and enters intermediate compartments of TVA950 cells and late endosome-like
compartments of TVA800 cells. Removal of NH4Cl initiates fusion with the limiting membrane of intermediate endosomes in TVA950 cells.
Subsequent dilation of a fusion pore releases the viral core (triangle) into the cytosol. In TVA800 cells, ASLV is trapped within a small intralumenal
vesicle, which is enclosed by a larger vesicle surrounded by the limiting membrane of an endosome. Fusion results in the content and core release
into a large intralumenal vesicle. The viral core then traverses two membranes via back-fusion of an enlarge vesicle with the limiting membrane of an
endosome (dashed arrow). The latter step is likely to be temperature-dependent and independent of ASLV Env.
doi:10.1371/journal.ppat.1002694.g007
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ligation with T4 DNA ligase (New England Biolab).
Virus production and transfections
Fluorescently labeled pseudoviruses were produced in
HEK293T/17 cells using PolyFect Transfection reagent (Qia-
gen, Valencia, CA). Cells grown on a 10 cm dish were
transfected with 2 mg MLV-Gag-Pol, 1 mg MLV-Gag-GFP or
MLV-Gag-mKO, 3 mg pMLV-LTR-LacZ and 3 mgo ft h e
cytoplasmic tail-truncated ASLV-A Env (EnvDCT). For ASLV
Env-pseudotyped virus carrying a membrane-incorporated GFP,
2 mg GFP-ICAM-1 were added to the transfection DNA
mixture. Twenty four hours post-transfection, cells were labeled
with 10 mM DiD in Opti-MEM (Invitrogen) for 4 h in the CO2
incubator at 37uC, as described in [41], washed, covered with
6 ml of fresh phenol red-free DMEM/10% FBS, and incubated
for an additional 24 h. Virus-containing medium was collected
48 h post-transfection, passed through a 0.45 mM filter, aliquot-
ed and stored at 280uC. The infectious titer was determined by
a b-Gal assay in CV-1 cells expressing TVA800, as described
previously [29,45]. To produce pseudoviruses containing the b-
lactamase-Vpr (BlaM-Vpr), a 10 cm dish of HEK293T/17 cells
was transfected with 2 mgp R 8 DEnv, 2 mg pMM310 vector
expressing BlaM-Vpr, 1 mgp c R e v ,a n d3mgE n v DCT expres-
sion vector, using PolyFect, as described above. The infectious
titer was determined by b-Gal assay in TZM-bl cells expressing
TVA950.
For transient expression of endosomal markers, CV-1 cells
expressing TVA800 or TVA950 were grown to 80% confluency
on glass-bottom 35 mm Petri dishes (Mattek, Ashland, Massachu-
setts) in phenol red-free DMEM. Cells were transfected with
0.5 mg of CFP-Rab5 and 0.5 mg YFP-Rab7, using Nanofectin
transfection reagent (PAA Laboratories, Dartmouth, MA), and
used for imaging 24 h post-transfection.
Virus-cell fusion assay
EnvDCT-pseudotyped pseudoviruses bearing the BlaM-Vpr
chimera were bound to CV-1 cells expressing TVA800 or
TVA950 in 96-well stripwell plates (Corning, NY) by centrifuga-
tion at 20956g, 4uC for 30 min (MOI=1). Unbound virus was
washed off with ice-cold HBSS, and cells were incubated in
isotonic HBSS/2% FBS (pH 7.8) containing 70 mM NH4Cl were
incubated for 45 min at 37uC. Fusion of internalized viruses
trapped in endosomes was initiated by transferring the cells into
HBSS/2% FBS supplemented with 50 mg/ml of Env-derived R99
peptide (to prevent fusion of not internalized viruses) for varied
times and stopped either by chilling the cells on ice (referred to as
the temperature block, TB) or by adding 70 mM NH4Cl
containing 50 mg/ml R99. The medium was removed from wells,
and cells were loaded with fluorescent CCF4-AM substrate
(Invitrogen) and incubated overnight at 12uC.
Imaging of single virus fusion
Unless stated otherwise, imaging experiments were performed
using the Personal DeltaVision imaging system (Applied Precision,
Issaquah, WA) equipped with an environmental enclosure that
maintained the samples at 37uC and high relative humidity.
Double- (Gag-GFP/DiD) and triple-labeled (Gag-mKO/GFP-
ICAM/DiD) viruses and cellular proteins tagged with a mono-
meric red fluorescent protein (mRFP-Rab5 and mRFP-Rab7)
were imaged using an UPlanFluo 406/1.3 NA oil objective
(Olympus) and a standard DAPI/FITC/TRITC/Cy5 filter set
(Chroma, Bellows Falls, VT). The fluorescence emission was
collected by an EM-CCD camera (Photometrics). For double-
labeled viruses, two consecutive images were collected every
1.5 sec for up to 10 min. Triple-labeled viruses were imaged every
2.2 seconds for the same period of time. In order to compensate
for the axial drift during acquisition, we used the UltimateFocus
feature (Applied Precision), which automatically compensates for
changes in the coverslip position.
CV-1 cells expressing either TVA950 or TVA800 receptor
were grown to near confluency on glass-bottom 35 mm Petri
dishes (Mattek) in phenol red-free growth medium. Cells were
placed on ice, washed with cold HBSS, and centrifuged with
,1.5?10
4 IU of viruses in 100 ml HBSS/2% FBS at 2,1006g
(4uC) for 20 min. Unbound viruses were removed by washing
with cold HBSS, and cells were incubated in isotonic HBSS/2%
FBS supplemented with 70 mM NH4Cl (pH=7.8) for 40 min at
37uC to allow virus uptake. For imaging, cells were transferred
into serum-free HBSS containing 70 mM NH4Cl and mounted
on the microscope stage maintained at 37uC. Solutions around
the cells in an image field were changed using a 4-channel
miniature perfusion system (Bioscience Tools, San Diego,
California) controlled through the Worx imaging software.
Solutions were applied locally through a 100 mm plastic tip
positioned close to the imaged cells, as described in [29]. The
following two pre-warmed solutions were applied to cells: HBSS
supplemented with 70 mM NH4Cl (pH=7.8) and plain HBSS
(pH=7.2). At the end of imaging experiments, cells were
returned to the NH4Cl-containing buffer.
Image analysis
Spot-enhancing filter 2D plugin from ImageJ [46] was applied
to background-subtracted images to improve the signal to noise
ratio. Virus tracking was performed with the 64-bit software
module from Imaris (BitPlane, Zurich, Switzerland), using an
auto-regressive algorithm. Tracking provided quantitative infor-
mation regarding the mean fluorescence intensities of the viral
content and membrane markers, particle’s instantaneous velocity,
trajectory and the mean square displacements (MSD). The two-
color kymographs were obtained, using the Volume Viewer plugin
from ImageJ.
The generalized two-dimensional diffusion coefficients (D) were
obtained from the y-axis intercepts (y0) for the MSD logarithmic
plot using the equation, as described in [47]:
D~ 4 ðÞ
{1:e
y0 ðÞ ð1Þ
Only the linear part of MSD following the core release was used to
calculate D. The linear MSD regime typically ranged from 10 to
25 seconds after core release. For co-localization analysis, images
were acquired after 40 min incubation with 70 mM NH4Cl at
37uC (unless stated otherwise), using the Zeiss LSM780 micro-
scope (Carl Zeiss Microscopy), and a 636/1.2 NA oil immersion
objective. Between 25 and 30 confocal Z sections were acquired
(0.3 mm apart) using a pinhole set at 1 Airy unit. Spectral
unmixing to correct for bleed-through between CFP-Rab5/YFP-
Rab7 and 3D image reconstruction were carried out with the Zen
and Imaris software, respectively. Image analysis for co-localiza-
tion was performed after subtracting the background, selecting a
meaningful range of apparent particle sizes (between 0.5 and
3 mm) and comparing the line histograms of CFP-Rab5, YFP-
Rab7 and Gag-mKate2 intensity distributions. A viral particle was
considered to be co-localized with an endosomal marker, if the
respective peaks of line histograms coincided (i.e., an endosomal
marker exhibited a local fluorescence maximum coinciding with
that of a viral particle).
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Figure S1 Measurements of endosomal pH using triple-
labeled pseudoviruses. (A) Changes in pH upon addition/
removal of NH4Cl. NH4
+ permeates through a lipid membrane in
its neutral ammonia form, which then acquires a proton and raises
the pH of the target compartment. Conversely, NH4
+ efflux leaves
excess protons and thus lowers the pH. (B) Distributions of
endosomal pH in CV-1 cells expressing TVA950. Cells were pre-
loaded with 40 mg/ml of pHrodo dextran according to the
manufacturer’s instructions, and fluorescence emission at 585 nm
was recorded. The fluorescence of pHrodo dextran increases at
low pH [23], so acidic compartments are brighter than neutral
endosomes. Total fluorescence intensity of single endosomes was
measured and normalized to the maximum fluorescence intensity
in control (untreated) cells. Graph shows the normalized
distribution of fluorescence intensities of endosomes in untreated
TVA950 cells (green bars), in the presence of 70 mM NH4Cl
(following a 40 min-incubation at 37uC, dark cyan bar), and
immediately after replacing NH4Cl with HBSS (NH4Cl/HBSS,
blue bars). (C) Changes in the average fluorescence of five pHrodo
dextran-laden endosomes in CV-1 cells upon perfusion with
70 mM NH4Cl in HBSS (white horizontal bar) with an
intermittent perfusion with plain HBSS for 2 min (black horizontal
bar). (D) Pseudoparticles carrying ASLV-A Env were co-labeled
with MLV Gag-mKO (core), GFP-ICAM-1 (membrane) and DiD
(membrane). Viruses were allowed to adhere to poly-L-lysine
coated coverslips and imaged at room temperature in buffers
adjusted to different pH values. Only particles positive for all three
markers, Gag-mKO (blue), GFP-ICAM-1 (green) and DiD (red)
where used for analysis (exemplified by two encircled white
particles on the top right panel. The pH 5.2 citrate buffer strongly
reduces the GFP-ICAM-1 fluorescence (lower panel) without
affecting the reference DiD signal or Gag-mKO fluorescence. (E)
Changes in the GFP fluorescence in response to citrate buffers of
different acidity. Buffers were applied to coverslip-immobilized
viruses through a local perfusion, starting with the pH 7.0 HBSS,
followed by a citrate buffer adjusted to an indicated pH between
4.6 and 6.3. Samples were perfused with neutral HBSS at the end
of experiment. The experimental data were smoothed using a
running average algorithm. (F) The pH calibration curve obtained
by plotting the average ratio of GFP-ICAM-1 and DiD signals
from 10 viruses as a function of pH. The last 5 time points of the
GFP and DiD signals in panel E before returning to a neutral
buffer were used for the calibration curve.
(TIF)
Figure S2 Dynamics of endosomal, cytosolic and in-
traviral pH upon removal of NH4Cl. (A) The average
intensity profiles for non-fusogenic ASLV pseudoviruses labeled
with GFP-ICAM-1, DiD and MLV Gag-mKO (pooled data using
cells expressing TVA800 and TVA950). Cells were perfused with
NH4Cl (white horizontal bar) followed by a 2 min-perfusion with
HBSS (black bar). The changes in average fluorescence ratio of
GFP over DiD of 20 randomly chosen particles following the
NH4Cl removal/addition are shown (green circles). The average
pH trace (pink line) was obtained from the calibration curve shown
in Figure S1F. Error bars correspond to the standard deviation
from the 20 GFP/DiD ratios was obtained for each time point. (B)
TVA800 and TVA950 cells transiently expressing cytosolic eGFP
were stained with DiD and imaged. The average ratio of GFP/
DiD (green dots) was obtained for selected regions of interest
within different cells. The corresponding error was obtained by
calculating the standard deviation of each time point for every
GFP/DiD measurement. The corresponding average pH trace
(pink line) was obtained from the calibration curve shown in
Figure S1F. The resting cytosolic pH value was set to 7.3, as shown
in [25]. (C) Average decay in the intraviral Gag-GFP (plotted as
Gag-GFP/DiD ratio) caused by removal of NH4Cl. Each datum
point is obtained by averaging fluorescence ratios from 20
randomly chosen viral particles. The corresponding pH trace
(pink line) was obtained from the calibration curve shown in
Figure 1F.
(TIF)
Figure S3 Analysis of releasable Gag-GFP pool in ASLV
pseudoviruses. (A) ASLV pseudoviruses co-labeled with Gag-
GFP/DiD were immobilized on coverslips and treated with
0.1 mM saponin at room temperature. Images were taken before
and 2–3 min after exposure to saponin, which mediated a quick
loss of green fluorescence puncta without noticeably affecting the
DiD fluorescence. (B) Analysis for the particles before and after
saponin treatment showed that 30% were completely resistant to
lysis, 23% lost only a portion of their fluorescence, and 47%
completely lost the GFP marker. The partial release phenotype
was unlikely due to virus aggregation, since larger particles were
excluded from analysis.
(TIF)
Figure S4 Incomplete separation of GFP- and DiD-
labeled puncta during the NH4Cl arrest/release proto-
col. ASLV pseudoviruses co-labeled with Gag-GFP (green) and
DiD (red) were subjected to the NH4Cl arrest/release protocol in
TVA950 cells (see Materials and Methods for details). (A) In spite
of the lack of full separation of green and red puncta (image
panels), the GFP fluorescence changes (green dots) during both
HBSS perfusion intervals paralleled the changes in the cytosolic
pH (pink lines) under the same perfusion conditions. The right
panel shows the trajectories of the SVP (green) and an endosome
(red). The initial, fully overlapping part of the trajectory is colored
blue. (B) Line histograms showing the spatial overlap of GFP-Gag
(green line) and DiD (red) puncta before (t=0, left) and after
(t=140 sec, right) partial SVP separation from an endosome.
(TIF)
Figure S5 Examples of SVP release (single HBSS pulse).
Two examples of spatial separation of GFP- and DiD-tagged
puncta following the NH4Cl arrest/release protocol for TVA800
cells (A) and TVA950 cells (B). In all cases, SVP release occurred
during HBSS perfusion (blue asterisk) and is detected by the
abrupt drop in the DiD intensity signal (red circles). The cytosolic
pH profile (pink lines in all panels) is also shown. In the case of
TVA800 cells (A), the GFP fluorescence recovery occurs only after
returning to NH4Cl (t=180 sec), a behavior expected for
endosomal compartments. In TVA950 cells the change in GFP-
Gag intensity after SVP release paralleled that of cytosolic pH,
suggesting that the viral capsid was released into the cytoplasm.
The trajectories for the GFP-tagged SPVs (solid green line)
together with the DiD-recipient vesicle trajectories (solid red line)
are shown below each intensity profile. In all cases, the motilities of
SVPs after their separation from endosomes were different from
those of endosomes that received DiD. Clearly, the SPV
movement is more restricted in TVA800 cells (A) than in
TVA950 cells (B). Diffusion coefficients (calculated as described
in Materials and Methods) shown next to the trajectories are 2-fold
greater for SPVs tracked in TVA950 cells compared to TVA800
cells.
(TIF)
Figure S6 Examples of spatial SVP release (double
HBSS pulse). Examples of delayed spatial separation of GFP-
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protocol in TVA800 (A) and TVA950 cells (B). SVPs were
released after the first HBSS perfusion pulse, which ended at
t=180 sec. Therefore a second HBSS pulse was applied (between
240 and 360 sec) to assess the localization of the released cores.
This protocol revealed different pH environment for the released
capsids in cells expressing alternative TVA receptors. The pH
profile of the cytosol (solid pink line in all panels) shows a fast
recovery following the first and the second HBSS pulses. This
behavior is matched by the GFP intensity profiles from SPVs
(green dots) released into TVA950 cells (B), but not into TVA800
cells (A). The trajectories for the GFP-Gag (solid green line) signal
together with the DiD (solid red line) are also shown under each
intensity profile. Comparison of the SVP trajectories in TVA800
and TVA950 cells shows that their mobility was more restricted in
TVA800 cells (see also Figure 3 and Figure S5). The diffusion
coefficients calculated as described in the Materials and Methods
are also given for the representative particles.
(TIF)
Figure S7 Example of core release into an endosome of
a TVA950 cell. (A) Spatial separation of GFP- and DiD-tagged
puncta in a TVA950 cell occurred during HBSS perfusion (blue
asterisk) as evidenced by the abrupt drop in the DiD intensity (red
circles). The GFP fluorescence recovers only after returning to
NH4Cl (t=180 sec), suggesting the SVP release into an endosomal
compartment. The endosome and SVP trajectories are shown in
B. The mean square displacement of SVP and DiD are also
depicted in C. The linear part of the MSD after SVP release
(between dashed lines in C) was chosen to generate a log-log plot
for the MSD over time (D). The diffusion coefficient
(D=0.16 mm
2/sec) of SVP was calculated using the y0 value
determined from the intercept of a linear fit with the Y axis and
applying Eq. 1 (see the main text for details).
(TIF)
Figure S8 Single ASLV fusion with Rab5-positive endo-
some. TVA950 cells were transiently transfected with a marker
for early endosomes, mRFP-Rab5 (A). ALSV pseudoviruses co-
labeled with Gag-GFP (green) and DiD (blue) were internalized by
cells in the presence of NH4Cl for 40 min at 37uC. Cells were
initially perfused with 70 mM NH4Cl in HBSS followed by
perfusion with plain HBSS for 2 min (black horizontal bars) and,
finally, with NH4Cl. (A, B) Fusion with a Rab5-positive endosome
in TVA950 cell is illustrated. Double-labeled viruses co-localized
with mRFP-Rab5 endosomes (red) appear white. The white
square in (A), delineates a region of interest magnified in (B) and
shown for different time points corresponding to perfusion with
different buffers t=0 sec (NH4Cl), t=90 sec (HBSS) and
t=250 sec (NH4Cl). The arrowheads in the merged panels mark
two particles undergoing fusion in Rab5-positive endosomes. (C)
Fusion was associated with a complete loss of GFP fluorescence
(green circles) from virions during the HBSS perfusion, while the
fluorescence intensities of DiD (blue circles) and mRFP-Rab5 (red
circles) remained steady. The corresponding two-color kymograph
(DiD/Gag-GFP) and three-color kymograph (DiD/Gag-GFP and
mRFP-Rab5) are also shown. For comparison, the intensity profile
for a non-fusogenic particle within a Rab5-positive endosome is
shown in panel D along with the corresponding two-color
kymograph (DiD/Gag-GFP).
(TIF)
Video S1 Failure of internalized ASLV pseudovirus to
fuse upon HBSS perfusion is associated with reversible
quenching of fluorescence of the GFP-tagged viral
content marker. An ASLV pseudovirus co-labeled with Gag-
GFP and DiD was internalized by a CV-1/TVA950 cell in the
presence of NH4Cl. Cells were sequentially perfused with 70 mM
NH4Cl in HBSS followed by perfusion with plain HBSS for 2 min
(as indicated in the upper left corner) and, finally, with NH4Cl.
The GFP signal from virion fully recovered after returning to
NH4Cl. The movie is played at 5 frames/sec.
(AVI)
Video S2 Synchronized fusion of an ASLV pseudovirus
with an endosome. A pseudovirus co-labeled with Gag-GFP
and DiD was internalized by a CV-1/TVA950 cell in the presence
of NH4Cl. Cells were initially perfused with 70 mM NH4Cl in
HBSS (as indicated at the left corner of the field) followed by
perfusion with plain HBSS for 2 min (white thick horizontal letters
at the left corner of the video) and, once more, with NH4Cl. Virus-
endosome fusion is initiated during the HBSS perfusion, which
results in acidification of endosomal lumen. Virus-endosome
fusion is manifested in irreversible loss of the GFP-tagged content
marker. The movie is played at 5 frames/sec.
(AVI)
Video S3 Spatial separation of GFP- and DiD-tagged
puncta in a TVA950 cell following the NH4Cl arrest/
release protocol. A co-labeled particle split into two during
HBSS perfusion (white circle), and the green and red sub-particles
continued to drift apart (thick lines indicating trajectories). The
fluorescence profile shown in Figure 2B was obtained for the
particle shown in this movie. The movie is played at 5 frames/sec.
(AVI)
Video S4 Spatial separation of GFP- and DiD-tagged
puncta in a TVA800 cell following the NH4Cl arrest/
release protocol. A co-labeled particle undergoes split into two
during HBSS perfusion (white circle), the restricted mobility and
change in intensity after changing HBSS to NH4Cl is apparent.
The fluorescence profile shown in Figure 2C was obtained for the
particle shown in this movie. The movie is played at 5 frames/sec.
(AVI)
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